Elevated FGF-23 is an independent risk factor for end-stage renal disease in patients with relatively preserved kidney function and for mortality across the spectrum of chronic kidney disease.
No takes yet. Share an insight, caveat, or question.
Tamara Isakova (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: